Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

ELQ-300, an investigational drug for treating and preventing malaria, shows potent transmission-blocking activity in rodent models of malaria.

Saved in:
Bibliografiske detaljer
Main Authors: Aaron Nilsen, Alexis N. LaCrue, Karen L. White, Isaac Forquer, R. Matthew Cross, Jutta Marfurt, Michael W. Mather, Michael J. Delves, David M. Shackleford, Fabián E. Saénz, Joanne M. Morrisey, Jessica Steuten, Tina Mutka, Yuexin Li, Grennady Wirjanata, Eileen Ryan, Sandra Duffy, Jane X. Kelly, Boni F. Sebayang, Anne‐Marie Zeeman, Rintis Noviyanti, Robert E. Sinden, Clemens H. M. Kocken, Ric N. Price, Vicky M. Avery, Íñigo Angulo‐Barturen, Marı́a Belén Jiménez-Dı́az, Santiago Ferrer, Esperanza Herreros, Laura M. Sanz, Francisco‐Javier Gamo, Ian Bathurst, Jeremy N. Burrows, Peter K. S. Siegl, R. Kiplin Guy, Rolf W. Winter, Akhil B. Vaidya, Susan A. Charman, Dennis E. Kyle, Roman Manetsch, Michael K. Riscoe
Format: Artigo
Sprog:engelsk
Udgivet: 2013
Online adgang:https://doi.org/10.1126/scitranslmed.3005029
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!